Since metabolic alterations induced by mannoheptulosc appear to affect fatty acid synthesis, the present study was conducted to elucidate this relationship. The results indicate that mannoheptulose suppresses hepatic fatty acid synthesis as indicated by a reduced incorporation of glucose-"C into fatty acids and by a decreased activity of acetyl CoA carboxylase. Fatty acid synthesis was restored by exogenous insulin Mannoheptulose had no effect on the activity of several other lipogenic enzymes and did not affect adipose tissue fatty acid synthesis. The effect of mannoheptulose in the liver appears to be mediated by glucagon.
Ingestion or subcutaneous administration of mannoheptulose (MH), a seven-carbon sugar naturally occurring in avocado fruit (1) , induces temporary hyperglycemia in man and in several animal species (2) (3) (4) . In addition, plasma levels of free fatty acids and ketone bodies rise shortly after MH administration (5) . The mechanism by which MH induces these metabolic changes is believed to be partially an inhibition of insulin secretion from the pancreas (6) , and a direct stimulation of hepatic gluconeogenesis as indicated by nitrogen bal ance studies and incorporation of 14C from serine into blood glucose (7) . MH also in creases steady state concentrations of he patic citrate, phosphoenolpyruvate, ketone bodies, adenosine mono-and diphosphate, and reduces the levels of adenosine triphosphate and fructose diphosphate (5 ) .
These metabolic alterations would indi cate an inhibition of hepatic glycolysis and a stimulation of gluconeogenic processes in MH-treated animals. There is ample evi dence demonstrating that fatty acid syn thesis is directly related to glycolytic rate and substrate availability (8) . Conse quently, it would appear likely that meta bolic alterations induced by MH would sup press the synthesis of fatty acids. The pres ent study was directed at this problem.
EXPERIMENTAL
Male Holtzman rats ranging in weight from 180 to 200 g were used in all experi ments. They were individually housed at 25Â°in galvanized wire cages and fed a synthetic diet for 10 days before experi mentation. The diet contained by weight the following components: 20% casein; 73^sucrose; 3% corn oil, 4% USP salt mixture XIV 4 and a complete vitamin sup plement. 5 Three hours thereafter the animals were decapitated, blood was collected in heparinized beakers, and livers and epididymal fat pads were quickly excised and collected in ice-cold saline. Liver slices, prepared with a Stadie-Riggs microtome,6 and fat pads were incubated in 25-ml Erlenmeyer flasks containing 3.0 ml of Krebs-Ringer bi carbonate buffer (pH 7.4), and 30 AmÃ³les of glucose with 0.25 /Â¿Ciglucose-U-14C. The flasks were gassed for 1 minute with 95% Oz-5% CO2 and stoppered with a rubber stopper from which a plastic well was suspended. All flasks were incubated in a shalcer apparatus " for 2 hours at 37Â°a t 100 strokes/minute. At the end of the incubation period, substrate incorporation into fatty acids and "CO2 was measured according to the methods described pre viously (9, 10) .
In vitro effects of MH on glucose oxida tion and incorporation into fatty acids were studied by increasing the MH concentra tion in incubation media. Where applica ble, insulin was added at 0.1 unit/ml of medium.
Another portion of liver was homog enized according to the method of Muto and Gibson ( 11 ) and the soluble liver supernatant obtained by centrifugation at 105,000 X g for 30 minutes was used to assay for the following enzymes by pre viously described methods: glucose-6-phosphate dehydrogenase, EC 1. 
RESULTS
As indicated in table l, MH reduced fatty acid synthesis in liver by approximately 71%, but had no effect on glucose oxida tion. MH did not affect fatty acid synthesis or glucose oxidation in adipose tissue.
The data in table 2 show that MH in hibited hepatic fatty acid synthesis from glucose-U-C14 by 76%, from glucose-l-14C and -6-14C by about 88 and 86%, respec tively. In every case, the synthesis was re stored by exogenous insulin.
The results of the enzyme assays are summarized in table 3. Compared to the control value, MH reduced the activity of acetyl CoA carboxylase by 64%. Again, the activity was fully restored by insulin ad ministration. MH had no effect on the activ ities of glucose-6-phosphate-, NADP malic-, and isocitrate dehydrogenase, citrate cleav age enzyme or fatty acid synthetase.
The in vitro effects of graded levels of MH on glucose oxidation and fatty acid synthesis are given in table 4. At the level of 1 mg/ml without insulin in the medium, MH reduced glucose oxidation and fatty acid synthesis by 55 and 64%, respectively. The inhibition was even greater when the concentration of MH in the medium was increased to 10 mg/ml. The presence of insulin in the medium failed to restore glucose oxidation or fatty acid synthesis.
DISCUSSION
Administration of MH to the intact rat produces a diabetic-like syndrome charac terized by hyperglycemia, ketonemia, ele vation of plasma free fatty acids and, as found in this study, an inhibition of hepatic fatty acid synthesis. The decreased incor poration of 14Cinto fatty acids was accom panied by a parallel reduction in the ac tivity of acetyl CoA carboxylase, the ratelimiting enzyme of fatty acid synthesis in animal tissue (19, 20) . In contrast, the other enzymes usually associated with lipogenesis were not affected by MH.
Acetyl-CoA carboxylase, it might be noted, is subject to activation or inhibition by a number of metabolic intermediates. It is activated by citrate (21, 22) and inhib ited by palmitoyl-CoA (23) or free fatty (24) . Long-chain acyl-CoA com pounds may also decrease the activity of the enzyme indirectly by inhibiting the activity of citrate synthetase, thus depriv ing the carboxylase of its activator (25, 26) . Acetyl-CoA carboxylase is also subject to hormonal control, that is, the activity is inhibited by growth hormone (27) , and, as recently reported from this laboratory, by glue-agon (28) . As a consequence, glucagon markedly reduces in vivo and in vitro incorporation of glucose into hepatic fatty acids (28, 29) , which, in magnitude, is similar to that reduced by MH. Indeed, administration of MH or glucagon elicits similar metabolic effects. Both compounds stimulate free fatty acid release from adi pose tissue, increase ketone production and reduce fatty acid synthesis by reducing acetyl-CoA carboxylase. Thus, the interpre tation of metabolic alterations induced by MH observed in this study may be based upon insulin insufficiency or, more specifi cally, upon hyperglucagonemia. This view is further substantiated by the fact that an infusion of MH into the dog over a period of 1 hour causes a progressive rise in plasma glucose, a fall of plasma insulin to undetectable levels and about a fivefold rise in plasma glucagon (30) . It would appear that the regulation of hepatic acetylCoA carboxylase by MH or glucagon in volves some activation-inactivation mecha nism analogous to the phosphorylation-dephosphorylation mechanisms known in glycogen metabolism (31) (32) (33) .
The mechanism by which MH induces high glucagon levels remains obscure. MH apparently inhibits phosphorylation of glu cose in the pancreatic ÃŸ-cells, a metabolic event necessary for insulin release (34) . The concomitant rise in glucagon can not however, be ascribed to hypoinsulinemia per se, since the infusion of MH plus in sulin does not prevent the rise of glucagon ( 30 ) . Inhibition of glucose phosphorylation by MH in the pancreatic a-cells perhaps is the necessary signal for the glucagon re lease. The resulting decline in the insulinglucagon molar ratio thus favors mobiliza tion of nutrient stores. In contrast, adminis tration of insulin, resulting in a rise of the insulin to glucagon ratio, will promote storage of nutrients and will effectively overcome metabolic alterations induced by MH.
The failure of MH to reduce fatty acid synthesis in adipose tissue can not be ade quately explained. Since it is thought that the inhibition of hepatic fatty acid syn thesis by MH is mediated by glucagon, and consequently, by cyclic AMP, it ap pears that such inhibitory mechanisms may be ineffective in adipose tissue. Alterna tively, fatty acid synthesis in adipose tissue may be controlled by mechanisms different from those observed in hepatic tissue. The in vitro inhibitory effect of MH on fatty acid synthesis ( table 4 ) could be attributed to a severe reduction of glucose phos phorylation in liver slices (34) which, in turn, decreases net glucose uptake. The Eresence of insulin in the incubation media died to restore lipogenesis. Since insulin fully restored in vivo fatty acid synthesis, it would appear that this in vitro metabolic effect of MH is of little significance in the intact animal.
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